Ketamine for Depression vs Chronic Pain: Why One Protocol Does Not Fit All

Ketamine is increasingly used in modern medicine for both treatment-resistant depression and chronic pain. While the same medication is used in both settings, it is a mistake to assume that the treatment protocols are interchangeable.

In reality, ketamine therapy for depression and ketamine therapy for pain are fundamentally different in their intent, dosing, and clinical application. Understanding these differences is essential for both patients and referring clinicians.

A shared mechanism, but different clinical goals

At a biological level, ketamine works primarily through modulation of the glutamatergic system, particularly via NMDA receptor antagonism. This leads to downstream effects on neuroplasticity, including activation of pathways such as BDNF and mTOR, which are thought to underpin its rapid therapeutic effects.

However, the clinical targets differ significantly.

In depression, ketamine is used to:

• Rapidly reduce depressive symptoms
• Improve mood and cognitive function
• Decrease suicidal ideation

In chronic pain, ketamine is used to:

• Reduce central sensitisation
• Modulate pain pathways
• Improve function and reduce reliance on opioids

Although the same neurochemical pathways are involved, the way ketamine is applied clinically is tailored to these distinct goals.

Differences in dosing and administration

One of the most important distinctions lies in how ketamine is dosed.

In depression, ketamine is typically administered at lower, sub-anaesthetic doses, most commonly around 0.5 mg/kg delivered over 40 minutes. The goal is to achieve a neuropsychiatric effect without deep sedation.

In contrast, ketamine protocols for chronic pain often involve:

• Higher doses, sometimes delivered over longer periods
• Infusions that may last several hours
• In some cases, multi-day inpatient treatment

These higher doses are designed to target more entrenched pain mechanisms, particularly in conditions involving central sensitisation.

As a result, applying a depression protocol to a pain condition — or vice versa — will often lead to suboptimal outcomes.

Frequency and treatment structure

Ketamine treatment for depression is usually structured as an induction and maintenance model. Patients may receive:

• A series of treatments over several weeks
• Followed by ongoing maintenance at intervals tailored to response

The aim is to stabilise mood and sustain improvement over time.

In chronic pain, treatment protocols are often more variable. Some patients may undergo:

• Intensive infusion programs over a short period
• Followed by reassessment and repeat treatment if required

The focus may be less on regular maintenance and more on resetting pain pathways and improving function.

The role of adjunctive therapies

Another key difference is how ketamine is integrated into broader care.

In depression, ketamine is typically combined with:

• Psychiatric review
• Psychological therapies
• Medication optimisation

The treatment is part of a broader mental health framework.

In chronic pain, ketamine is integrated into a multidisciplinary rehabilitation model, often involving:

• Physiotherapy
• Functional restoration
• Pain education strategies

The goal is not only pain reduction, but improved physical function and quality of life.

Why protocols cannot be standardised

Given these differences, it becomes clear that a single “ketamine protocol” cannot be universally applied.

Each treatment approach must consider:

• The underlying condition (psychiatric vs pain)
• The severity and chronicity of symptoms
• Patient-specific factors, including comorbidities
• The intended therapeutic outcome

Using a uniform approach risks:

• Under-treatment of complex pain conditions
• Over-treatment or inappropriate dosing in psychiatric settings
• Reduced effectiveness overall

The importance of clinical expertise

Ketamine is not a one-size-fits-all treatment. Its effectiveness depends heavily on how it is delivered.

Appropriate use requires:

• Careful patient selection
• Individualised dosing
• Ongoing monitoring and review
• Integration into a broader treatment plan

Clinicians experienced in both mental health and pain medicine are uniquely positioned to navigate these complexities and tailor treatment accordingly.

Final thoughts

Ketamine is a versatile and powerful treatment, but its use in depression and chronic pain represents two distinct clinical applications.

While the underlying pharmacology overlaps, the protocols, dosing strategies, and therapeutic goals differ significantly. Applying the same treatment approach across both conditions is unlikely to achieve optimal results.

As the field evolves, the focus is increasingly shifting toward precision and individualisation, ensuring that ketamine therapy is matched to the specific needs of each patient.

Disclaimer

Anodyne is a specialised health service focused on patient centred and novel approaches for pain management and mental health treatments.

Any advice posted on our blog, website, or app is of a general nature and for informational purposes only. It is not intended to replace or substitute for any medical or other advice.

Anodyne makes no representations or warranties and expressly disclaim any and all liability concerning any treatment, action by, or effect on any person following the general information offered or provided within or through the blog, website, or app. If you have specific concerns or a situation arises in which you require medical advice, you should consult with an appropriately trained and qualified medical practitioner.

Seeking Support for Depression or Pain?

If you or your patient is experiencing persistent or difficult-to-manage pain or depression, our team can help.

Contact us: Opens in new window - Opens in new tab to explore advanced psychiatric and pain management options tailored to your needs.